Kevin Driver, MD
Cardiac Electrophysiology · Charleston
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 10
Offices
10 locations · Charleston Area Medical Center Inc · 969 clinicians in this group
Hospitals listed: Beckley Arh Hospital · Charleston Area Medical Center · Thomas Memorial Hospital. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Driver’s office to ask if they take your plan before you enroll.
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Beckley Arh HospitalBeckley, WVAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Appalachian Regional Healthcare, which runs 14 hospitals in 2 statesPatients rate it 3 of 5 · 69% would definitely recommend itOverall rating: 3 of 5 starsNo measure marked better or worse than the national rate
- Charleston Area Medical CenterCharleston, WVAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of CAMC Health System, which runs 8 hospitalsPatients rate it 3 of 5 · 69% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — CMS Medicare PSI 90: Patient safety and adverse events composite: 1.92 (1.69 to 2.15), Jul 2022 – Jun 2024Worse than the national rate — Postoperative acute kidney injury requiring dialysis rate: 3.64 (2.35 to 4.92) · 1,212 cases, Jul 2022 – Jun 2024Worse than the national rate — Postoperative hemorrhage or hematoma rate: 3.64 (2.48 to 4.81) · 3,238 cases, Jul 2022 – Jun 2024Worse than the national rate — Postoperative sepsis rate: 10.6 (7.55 to 13.65) · 1,150 cases, Jul 2022 – Jun 2024Worse than the national rate — Pressure ulcer rate: 2.39 (1.93 to 2.85) · 11,416 cases, Jul 2022 – Jun 2024Worse than the national rate — MRSA Bacteremia: 1.642, Oct 2024 – Sep 2025Worse than the national rate — SSI - Colon Surgery: 1.578, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.563, Oct 2024 – Sep 2025Better than the national rate — SSI - Abdominal Hysterectomy: 0, Oct 2024 – Sep 2025
- Thomas Memorial HospitalSouth Charleston, WVAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of West Virginia University Health System, which runs 23 hospitals in 4 statesPatients rate it 3 of 5 · 71% would definitely recommend itOverall rating: 1 of 5 starsWorse than the national rate — CMS Medicare PSI 90: Patient safety and adverse events composite: 1.68 (1.3 to 2.07), Jul 2022 – Jun 2024Worse than the national rate — Pressure ulcer rate: 2.55 (1.66 to 3.44) · 3,058 cases, Jul 2022 – Jun 2024Worse than the national rate — Clostridium Difficile (C.Diff): 1.445, Oct 2024 – Sep 2025
See every measure and the patient survey for Beckley Arh Hospital
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 1 better, 3 the same, 0 worse of 4 measures. Readmissions: 0 better, 5 the same, 2 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.02 (0 to 2.1) · 200 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.84 (0.42 to 1.26) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.87 (108.47 to 227.26) · 39 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.8 · 49 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.6 · 91 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.5 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.8 · 267 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 15.4 · 55 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.6 · 940 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.42) · 2,046 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.04 to 0.46) · 2,167 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.1 (0.61 to 5.59) · 267 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.65 (0 to 3.37) · 44 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.15 (0.49 to 3.82) · 260 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.44 (0 to 18.1) · 49 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.17 (0.86 to 9.49) · 34 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.74 (0.22 to 3.26) · 34 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.28 (0 to 1.18) · 1,689 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.681 | No different | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 1.123 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.2 · 127 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.9 · 245 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -9.1 · 82 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 51.7 · 154 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 61.5 · 274 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.1 · 440 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.2 · 123 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.9 (9.6 to 17.3) · 315 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 63 cases | No different | Jan 2024 – Dec 2024 |
What patients said (196 patients answered, 21% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 3 |
| Room was "always" clean | 68% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 72% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 69% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Charleston Area Medical Center
Behind the star rating — Deaths: 1 better, 6 the same, 1 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 6 the same, 5 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.92 (1.69 to 2.15) | Worse | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 3.64 (2.35 to 4.92) · 1,212 cases | Worse | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 3.64 (2.48 to 4.81) · 3,238 cases | Worse | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 10.6 (7.55 to 13.65) · 1,150 cases | Worse | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 2.39 (1.93 to 2.85) · 11,416 cases | Worse | Jul 2022 – Jun 2024 |
| MRSA BacteremiaInfections | 1.642 | Worse | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.578 | Worse | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.95 (0.12 to 1.79) · 2,424 cases | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 185.48 (148.36 to 222.6) · 223 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.7 · 274 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.6 · 285 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.7 · 448 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.3 · 663 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.7 · 736 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12.8 · 841 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.5 · 7,444 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.32 (0.14 to 0.5) · 12,215 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.03 to 0.39) · 13,062 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.09 (3.39 to 6.78) · 3,408 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.39 (7.26 to 15.52) · 1,162 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.63 (0.28 to 2.97) · 718 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.2 · 44 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.856 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.958 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.3 · 830 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.7 · 1,545 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 10.8 · 488 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 44.9 · 754 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 40.9 · 762 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.2 · 1,470 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.9 (4.5 to 7.8) · 423 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.7 (9.6 to 14.3) · 423 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.8 · 41 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 14.1 · 446 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.5 · 736 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.1 (9.5 to 15.5) · 1,389 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.2) · 922 cases | No different | Jan 2024 – Dec 2024 |
What patients said (2,799 patients answered, 21% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 69% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 68% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 69% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
See every measure and the patient survey for Thomas Memorial Hospital
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 0 better, 6 the same, 1 worse of 7 measures. Readmissions: 1 better, 7 the same, 2 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.68 (1.3 to 2.07) | Worse | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 2.55 (1.66 to 3.44) · 3,058 cases | Worse | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 1.445 | Worse | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.39 (0.38 to 2.39) · 774 cases | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 149.96 (92.71 to 207.2) · 43 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.8 · 133 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.9 · 87 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.9 · 211 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 17.2 · 284 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 13.9 · 92 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 3,125 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.41) · 3,630 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.32 (0.12 to 0.53) · 3,707 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.73 (0.4 to 5.07) · 745 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.98 (0.32 to 3.65) · 291 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.98 (0.38 to 3.58) · 697 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 12.67 (4.8 to 20.55) · 328 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.83 (2.84 to 10.83) · 256 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.69 (0.19 to 3.18) · 178 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 63 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.74 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 1.303 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.899 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.288 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.9 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.3 · 550 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -36.3 · 79 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 20 · 228 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 33.3 · 315 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.1 · 710 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.3 (3.5 to 7.8) · 103 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.7 (8.7 to 15.6) · 103 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.9 · 69 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 56 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 321 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.9 (9.9 to 16.5) · 1,048 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.6 to 1.1) · 353 cases | No different | Jan 2024 – Dec 2024 |
What patients said (928 patients answered, 23% of those asked)
| Cleanliness | 1 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 60% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 84% |
| Doctors "always" explained things so they could understand | 72% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 69% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 74% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 49% |
| "YES", patients would definitely recommend the hospital | 71% |
| Staff "always" explained possible side effects | 48% |
| Yes, staff "did" give patients information about possible symptoms | 81% |
Original Medicare doctor bills
$110,691
Medicare paid this office $110,691 for 1,783 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 475 | $12,307 | $21 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 11 | $8,431 | $766 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 937 | $7,467 | $6 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 218 | $7,326 | $25 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 18 | $7,281 | $405 |
See all 24 services
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 475 | $12,307 | $21 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 11 | $8,431 | $766 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 937 | $7,467 | $6 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 218 | $7,326 | $25 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 18 | $7,281 | $405 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 67 | $7,207 | $100 |
| Insertion of permanent leadless pacemaker using imaging guidance | 14 | $4,638 | $331 |
| Return visit (30+ min) | 56 | $4,579 | $70 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 33 | $4,539 | $138 |
| New patient visit (45+ min) | 45 | $4,538 | $101 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 165 | $2,611 | $15 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 70 | $1,833 | $25 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 49 | $1,750 | $19 |
| Short return visit (20+ min) | 32 | $1,604 | $47 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 15 | $1,509 | $89 |
| New patient visit (30+ min) | 16 | $987 | $62 |
| External shock to heart to regulate heart beat | 12 | $927 | $77 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 41 | $785 | $19 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $690 | $63 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 65 | $621 | $9 |
| Programming of dual lead pacemaker system | 20 | $556 | $28 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | 21 | $403 | $18 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 15 | $300 | $20 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 11 | $58 | $5 |
Procedures Medicare counted
| Pacemaker insertion or repair | 49 | More than 89% of doctors who do this |
Who their Medicare patients are
1,783 Original Medicare patients in 2024. Average age 75 · Under 65 10% · 85 and older 19% · Women 46% · Also on Medicaid 17% · Health risk score 1.99. Above the middle of the specialty; the typical clinical cardiac electrophysiology clinician is at 1.8.
Conditions among them: High blood pressure 75% · Coronary heart disease 71% · Atrial fibrillation 60% · Heart failure 51% · Diabetes 48% · Chronic kidney disease 43% · COPD 34% · Depression 31% · Cancer 17% · Dementia 13% · Stroke 13%.
The office billed $571,499, Medicare allowed $143,201 and paid $110,691; for 3,152 services of 63 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 1,783 | 3,152 | 75 | 1.99 | $571,499 | $110,691 |
| 2023 | 1,715 | 3,005 | 76 | 1.88 | $641,116 | $127,126 |
| 2022 | 1,124 | 1,656 | 75 | 1.97 | $360,248 | $70,256 |
| 2021 | 1,824 | 3,297 | 75 | 1.99 | $674,811 | $145,331 |
| 2020 | 1,954 | 3,467 | 74 | 2.07 | $624,587 | $143,668 |
| 2019 | 2,158 | 3,745 | 73 | 2.13 | $664,608 | $160,809 |
| 2018 | 1,515 | 2,801 | 74 | 1.93 | $653,060 | $175,664 |
| 2017 | 1,251 | 2,029 | 74 | 1.88 | $472,530 | $136,447 |
| 2016 | 2,536 | 5,022 | 76 | 1.79 | $598,237 | $219,575 |
| 2015 | 420 | 906 | 75 | 1.71 | $214,703 | $75,731 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 25 services
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 483 | $12,660 | $21 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 84 | $11,640 | $134 |
| Insertion of permanent leadless pacemaker using imaging guidance | 26 | $9,718 | $374 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 12 | $8,979 | $748 |
| Insertion of implantable defibrillator system | 11 | $7,833 | $712 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 19 | $7,686 | $405 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 60 | $6,437 | $101 |
| New patient visit (45+ min) | 63 | $6,268 | $99 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 807 | $6,133 | $6 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 198 | $5,867 | $24 |
| Return visit (30+ min) | 59 | $4,541 | $73 |
| Insertion of left lower heart electrode for pacemaker or defibrillator | 11 | $4,017 | $365 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 177 | $2,814 | $15 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 85 | $2,472 | $27 |
| Critical care, first 30-74 minutes | 11 | $2,163 | $166 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 59 | $2,034 | $18 |
| New patient visit (30+ min) | 28 | $1,731 | $62 |
| Short return visit (20+ min) | 31 | $1,675 | $51 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 13 | $1,285 | $92 |
| External shock to heart to regulate heart beat | 14 | $1,239 | $83 |
| Programming of dual lead pacemaker system | 35 | $957 | $27 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 83 | $823 | $10 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $793 | $61 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 25 | $486 | $19 |
| Programming of dual lead implantable defibrillator system | 11 | $427 | $39 |
2022: 21 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 57 | $9,120 | $155 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 363 | $7,434 | $19 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 13 | $5,259 | $405 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 171 | $4,245 | $22 |
| Removal and replacement of dual lead permanent pacemaker | 11 | $3,131 | $285 |
| Critical care, first 30-74 minutes | 13 | $2,419 | $173 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 284 | $2,326 | $6 |
| Short return visit (20+ min) | 55 | $2,131 | $39 |
| New patient visit (45+ min) | 16 | $1,636 | $102 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 57 | $1,503 | $18 |
| New patient visit (30+ min) | 24 | $1,299 | $54 |
| Return visit (30+ min) | 19 | $1,231 | $65 |
| External shock to heart to regulate heart beat | 13 | $1,100 | $85 |
| Return visit (30+ min) | 14 | $885 | $63 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 27 | $760 | $27 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 48 | $739 | $15 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 34 | $646 | $19 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 50 | $530 | $10 |
| Programming of dual lead pacemaker system | 14 | $390 | $28 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 14 | $59 | $4 |
| Routine electrocardiogram (ecg) using at least 12 leads with tracing | 14 | $32 | $2 |
2021: 25 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 117 | $19,452 | $156 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 550 | $16,199 | $21 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 338 | $12,633 | $26 |
| Short return visit (20+ min) | 163 | $8,685 | $50 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 19 | $7,632 | $402 |
| Removal and replacement of dual lead permanent pacemaker | 25 | $6,533 | $261 |
| Insertion of permanent leadless pacemaker using imaging guidance | 14 | $5,309 | $379 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 647 | $5,188 | $6 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 40 | $4,284 | $104 |
| Return visit (30+ min) | 49 | $4,041 | $76 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 70 | $3,081 | $19 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 11 | $2,668 | $243 |
| New patient visit (30+ min) | 43 | $2,663 | $62 |
| Critical care, first 30-74 minutes | 13 | $2,283 | $176 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 17 | $1,624 | $81 |
| New patient visit (45+ min) | 14 | $1,407 | $101 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 67 | $1,328 | $20 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 60 | $959 | $15 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 95 | $957 | $10 |
| External shock to heart to regulate heart beat | 12 | $947 | $79 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 31 | $888 | $29 |
| Programming of dual lead pacemaker system | 25 | $709 | $28 |
| Programming of multiple lead implantable defibrillator system | 11 | $589 | $49 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 15 | $99 | $7 |
| Routine electrocardiogram (ecg) using at least 12 leads with tracing | 14 | $65 | $5 |
2020: 27 services
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 472 | $13,783 | $22 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 99 | $10,972 | $109 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 301 | $10,336 | $27 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 903 | $8,604 | $7 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 51 | $8,540 | $161 |
| Insertion of permanent leadless pacemaker using imaging guidance | 21 | $6,691 | $319 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 16 | $6,274 | $392 |
| Removal and replacement of dual lead permanent pacemaker | 20 | $5,534 | $277 |
| Short return visit (20+ min) | 126 | $5,095 | $38 |
| Insertion of left lower heart electrode for pacemaker or defibrillator | 12 | $4,735 | $395 |
| Return visit (30+ min) | 58 | $3,921 | $61 |
| Critical care, first 30-74 minutes | 22 | $3,795 | $173 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 77 | $3,197 | $21 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 12 | $2,996 | $250 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 21 | $1,330 | $55 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 59 | $1,251 | $21 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 42 | $1,143 | $26 |
| New patient visit (45+ min) | 11 | $1,130 | $103 |
| External shock to heart to regulate heart beat | 13 | $1,076 | $83 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 13 | $1,070 | $82 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 70 | $1,047 | $14 |
| Ultrasound of heart with probe in esophagus, with report | 11 | $968 | $88 |
| Telephone medical discussion with physician, 21-30 minutes | 14 | $940 | $59 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 89 | $914 | $10 |
| New patient visit (30+ min) | 20 | $823 | $41 |
| Programming of dual lead pacemaker system | 28 | $804 | $28 |
| Programming of multiple lead implantable defibrillator system | 12 | $606 | $50 |
2019: 28 services
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 161 | $18,438 | $108 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 324 | $12,167 | $29 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 445 | $11,642 | $20 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 12 | $11,338 | $945 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 24 | $9,960 | $415 |
| Insertion of implantable defibrillator system | 12 | $9,103 | $759 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 1,048 | $8,988 | $7 |
| Short return visit (20+ min) | 180 | $7,520 | $37 |
| Removal and replacement of dual lead permanent pacemaker | 20 | $5,620 | $281 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 13 | $3,242 | $249 |
| Critical care, first 30-74 minutes | 14 | $2,850 | $178 |
| Return visit (30+ min) | 44 | $2,622 | $58 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 15 | $2,397 | $160 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 68 | $2,351 | $19 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 73 | $1,980 | $27 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 89 | $1,524 | $16 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 24 | $1,494 | $57 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 12 | $1,356 | $113 |
| New patient visit (15+ min) | 37 | $1,196 | $32 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 62 | $1,183 | $19 |
| External shock to heart to regulate heart beat | 14 | $1,132 | $81 |
| New patient visit (45+ min) | 11 | $1,125 | $102 |
| Programming of dual lead pacemaker system | 38 | $1,114 | $29 |
| New patient visit (30+ min) | 16 | $969 | $61 |
| Programming of multiple lead implantable defibrillator system | 18 | $948 | $50 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 96 | $943 | $10 |
| Short return visit | 33 | $546 | $17 |
| Programming of dual lead implantable defibrillator system | 11 | $502 | $46 |
2018: 39 services
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 127 | $14,868 | $106 |
| Insertion of implantable defibrillator system | 19 | $14,735 | $737 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 299 | $13,532 | $41 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 14 | $12,969 | $926 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 25 | $10,185 | $407 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 315 | $8,376 | $23 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 237 | $8,083 | $32 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 282 | $5,643 | $18 |
| Insertion of left lower heart electrode for pacemaker or defibrillator | 13 | $5,042 | $388 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 16 | $4,208 | $263 |
| Removal and replacement of multiple lead defibrillator | 13 | $4,153 | $319 |
| New patient visit (45+ min) | 32 | $3,621 | $113 |
| Removal and replacement of dual lead permanent pacemaker | 12 | $3,194 | $266 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 73 | $2,608 | $36 |
| New patient visit (45+ min) | 24 | $2,425 | $101 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 36 | $2,380 | $55 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 15 | $2,370 | $158 |
| Short return visit (20+ min) | 60 | $2,271 | $38 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 23 | $2,029 | $81 |
| Return visit (30+ min) | 24 | $1,850 | $77 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 16 | $1,780 | $111 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 21 | $1,670 | $80 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 45 | $1,597 | $20 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 72 | $1,561 | $22 |
| New patient visit (30+ min) | 26 | $1,483 | $57 |
| Return visit (30+ min) | 24 | $1,467 | $59 |
| Short return visit (20+ min) | 26 | $1,286 | $48 |
| External shock to heart to regulate heart beat | 13 | $1,201 | $86 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 64 | $1,055 | $16 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 87 | $1,047 | $11 |
| New patient visit (30+ min) | 17 | $1,043 | $61 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 36 | $1,022 | $28 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 34 | $973 | $18 |
| Programming of dual lead pacemaker system | 22 | $901 | $41 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 132 | $886 | $6 |
| Programming of multiple lead implantable defibrillator system | 15 | $827 | $55 |
| Programming of dual lead pacemaker system | 26 | $814 | $29 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 17 | $387 | $20 |
| Telephonic rhythm strip evaluation of single, dual, multiple lead or leadless pacemaker system, up to 90 days | 11 | $165 | $12 |
2017: 25 services
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 323 | $20,312 | $51 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 393 | $12,462 | $26 |
| Insertion of implantable defibrillator system | 16 | $11,747 | $734 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 19 | $7,950 | $418 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 12 | $7,789 | $649 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 63 | $6,808 | $105 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 15 | $5,120 | $320 |
| New patient visit (45+ min) | 44 | $4,825 | $110 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 93 | $4,575 | $48 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 25 | $3,917 | $157 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 110 | $2,974 | $27 |
| Programming of dual lead pacemaker system | 70 | $2,483 | $35 |
| New patient visit (30+ min) | 28 | $2,208 | $79 |
| Return visit (30+ min) | 31 | $2,092 | $65 |
| Programming of multiple lead implantable defibrillator system | 30 | $2,014 | $65 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 50 | $1,744 | $20 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 27 | $1,720 | $54 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 130 | $1,394 | $10 |
| Insertion of catheters for recording and pacing of left upper heart chamber rhythm and induction of abnormal rhythm | 14 | $1,322 | $94 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 17 | $1,160 | $68 |
| Programming of dual lead implantable defibrillator system | 22 | $986 | $45 |
| Short return visit (20+ min) | 23 | $851 | $37 |
| Programming of single lead implantable defibrillator system | 16 | $749 | $47 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 11 | $657 | $55 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 14 | $478 | $30 |
2016: 38 services
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 32 | $20,634 | $645 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 24 | $20,620 | $859 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 56 | $17,015 | $304 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 1,906 | $16,327 | $6 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 155 | $12,439 | $53 |
| New patient visit (45+ min) | 95 | $10,766 | $113 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 127 | $10,003 | $75 |
| Return visit (30+ min) | 89 | $7,909 | $75 |
| Insertion of implantable defibrillator system | 11 | $7,715 | $701 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 18 | $7,177 | $399 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 63 | $6,469 | $103 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 88 | $5,146 | $57 |
| Short return visit (20+ min) | 86 | $4,865 | $47 |
| Destruction of heart conduction tissue to create heart block | 11 | $4,761 | $433 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 247 | $4,536 | $12 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 21 | $3,366 | $153 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 29 | $3,275 | $113 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 67 | $3,045 | $30 |
| Programming of dual lead pacemaker system | 68 | $2,837 | $30 |
| External shock to heart to regulate heart beat | 29 | $2,743 | $88 |
| Insertion of catheters for recording and pacing of left upper heart chamber rhythm and induction of abnormal rhythm | 30 | $2,681 | $89 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 28 | $2,673 | $79 |
| New patient visit (30+ min) | 20 | $1,465 | $73 |
| Remote evaluations of implantable heart and blood vessel monitor or loop recorder system with technician analysis, review, and report, up to 30 days | 15 | $1,406 | $20 |
| Short return visit | 44 | $1,355 | $29 |
| Programming of heart rhythm stimulation after drug infusion | 11 | $1,335 | $121 |
| New patient visit (60+ min) | 11 | $1,327 | $121 |
| Initial hospital observation care per day, typically 50 minutes | 13 | $1,322 | $94 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 16 | $1,279 | $18 |
| Follow-up observation care per day, typically 25 minutes | 18 | $1,164 | $51 |
| Programming of single lead pacemaker system | 26 | $890 | $27 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 24 | $875 | $23 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 38 | $766 | $20 |
| Hospital discharge day management, 30 minutes or less | 14 | $761 | $54 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 32 | $755 | $16 |
| Programming of dual lead implantable defibrillator system | 14 | $717 | $40 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 37 | $595 | $16 |
| Short return visit (20+ min) | 15 | $579 | $39 |
2015: 17 services
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 11 | $7,155 | $650 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 78 | $6,043 | $55 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 13 | $5,279 | $406 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 13 | $3,952 | $304 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 38 | $3,798 | $79 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 33 | $3,537 | $104 |
| New patient visit (45+ min) | 27 | $3,301 | $122 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 44 | $2,673 | $61 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 13 | $2,003 | $154 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 26 | $2,002 | $77 |
| Return visit (30+ min) | 23 | $1,831 | $80 |
| New patient visit (60+ min) | 11 | $1,694 | $154 |
| Long return visit (40+ min) | 13 | $1,401 | $108 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 88 | $1,361 | $12 |
| Short return visit (20+ min) | 20 | $1,177 | $53 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 139 | $1,032 | $6 |
| Programming of dual lead pacemaker system | 12 | $722 | $42 |
Medicaid work
$711 in 2024
Medicaid paid $711 for 363 billed services this clinician did in 2024, up to 64 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 329 | $616 |
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead implantable defibrillator system with interim analysis, review(s) and report(s) by a physician or other qualified health care professional | 18 | $52 |
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead pacemaker system, or leadless pacemaker system with interim analysis, review(s) and report(s) by a physician or other qualified health care professional | 16 | $43 |
| 2024 | 363 | 3 | 64 | $711 |
| 2023 | 295 | 3 | 106 | $306 |
| 2022 | 195 | 4 | 63 | $401 |
| 2021 | 877 | 5 | 239 | $4,605 |
| 2020 | 1,434 | 5 | 359 | $11,585 |
| 2019 | 840 | 4 | 198 | $7,876 |
| 2018 | 209 | 3 | 22 | $3,877 |
See the largest Medicaid services in earlier years
2023
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 266 | $306 |
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead pacemaker system, or leadless pacemaker system with interim analysis, review(s) and report(s) by a physician or other qualified health care professional | 12 | $0 |
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead implantable defibrillator system with interim analysis, review(s) and report(s) by a physician or other qualified health care professional | 17 | $0 |
2022
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 134 | $172 |
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead pacemaker system, or leadless pacemaker system with interim analysis, review(s) and report(s) by a physician or other qualified health care professional | 15 | $124 |
| Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 18 | $53 |
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead implantable defibrillator system with interim analysis, review(s) and report(s) by a physician or other qualified health care professional | 28 | $52 |
2021
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 716 | $2,730 |
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead implantable defibrillator system with interim analysis, review(s) and report(s) by a physician or other qualified health care professional | 79 | $957 |
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead pacemaker system, or leadless pacemaker system with interim analysis, review(s) and report(s) by a physician or other qualified health care professional | 43 | $519 |
| Interrogation device evaluation(s), (remote) up to 30 days; subcutaneous cardiac rhythm monitor system, including analysis of recorded heart rhythm data, analysis, review(s) and report(s) by a physician or other qualified health care professional | 27 | $367 |
| Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 12 | $32 |
2020
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 1,225 | $8,456 |
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead implantable defibrillator system with interim analysis, review(s) and report(s) by a physician or other qualified health care professional | 61 | $1,289 |
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead pacemaker system, or leadless pacemaker system with interim analysis, review(s) and report(s) by a physician or other qualified health care professional | 90 | $847 |
| Interrogation device evaluation(s), (remote) up to 30 days; subcutaneous cardiac rhythm monitor system, including analysis of recorded heart rhythm data, analysis, review(s) and report(s) by a physician or other qualified health care professional | 46 | $844 |
| Short return visit (20+ min) | 12 | $149 |
2019
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 770 | $6,331 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 14 | $1,029 |
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead pacemaker system, or leadless pacemaker system with interim analysis, review(s) and report(s) by a physician or other qualified health care professional | 31 | $266 |
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead implantable defibrillator system with interim analysis, review(s) and report(s) by a physician or other qualified health care professional | 25 | $249 |
2018
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead implantable defibrillator system with interim analysis, review(s) and report(s) by a physician or other qualified health care professional | 143 | $2,585 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 16 | $965 |
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead pacemaker system, or leadless pacemaker system with interim analysis, review(s) and report(s) by a physician or other qualified health care professional | 50 | $326 |
Drugs they prescribed that Part D paid
$85,623
Pharmacies billed $85,623 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 15% of their Part D prescriptions (55 of 363) in 2024. A higher opioid share than 9 in 10 peers; the typical clinical cardiac electrophysiology clinician is at 0%.
305 generic and 58 brand-name prescriptions · $85,623 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 38 | $52,558 | $1,383 |
| Multaq | 11 | $14,612 | $1,328 |
| Propafenone | 79 | $4,008 | $51 |
| Dofetilide | 16 | $3,921 | $245 |
| Metoprolol | 29 | $792 | $27 |
See all 9 drugs
| Eliquis | 38 | $52,558 | $1,383 |
| Multaq | 11 | $14,612 | $1,328 |
| Propafenone | 79 | $4,008 | $51 |
| Dofetilide | 16 | $3,921 | $245 |
| Metoprolol | 29 | $792 | $27 |
| Amiodarone | 50 | $694 | $14 |
| Oxycodone | 54 | $91 | $2 |
| Carvedilol | 24 | $63 | $3 |
| Metoprolol | 12 | $56 | $5 |
Year by year
| 2024 | 363 | 182 | 15% (55) | 16% | $85,623 |
| 2023 | 324 | 170 | 20% (64) | 22% | $102,872 |
| 2022 | 453 | 205 | 7% (33) | 35% | $219,097 |
| 2021 | 617 | 246 | 9% (53) | 37% | $298,042 |
| 2020 | 435 | 177 | 11% (49) | 38% | $168,295 |
| 2019 | 335 | 176 | 17% (56) | 39% | $117,670 |
| 2018 | 525 | 217 | 10% (50) | 35% | $166,398 |
| 2017 | 867 | 245 | 6% (48) | 28% | $142,946 |
| 2016 | 1,392 | 234 | 4% (50) | 30% | $190,681 |
| 2015 | 206 | 68 | 6% (13) | 30% | $20,716 |
| 2014 | 52 | 17 | None | 25% | $3,230 |
| 2013 | 125 | 26 | None | 21% | $4,456 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 7 drugs
| Multaq | 30 | $45,068 | $1,502 |
| Eliquis | 29 | $37,098 | $1,279 |
| Propafenone | 59 | $3,738 | $63 |
| Amiodarone | 64 | $1,096 | $17 |
| Flecainide Acetate | 11 | $654 | $59 |
| Metoprolol | 22 | $439 | $20 |
| Oxycodone | 63 | $132 | $2 |
2022: 10 drugs
| Eliquis | 110 | $128,714 | $1,170 |
| Multaq | 30 | $49,004 | $1,633 |
| Xarelto | 11 | $15,481 | $1,407 |
| Dofetilide | 19 | $8,096 | $426 |
| Propafenone | 38 | $2,838 | $75 |
| Metoprolol | 44 | $2,011 | $46 |
| Amiodarone | 102 | $1,489 | $15 |
| Flecainide Acetate | 16 | $1,373 | $86 |
| Sotalol | 12 | $286 | $24 |
| Oxycodone | 33 | $92 | $3 |
2021: 11 drugs
| Eliquis | 149 | $159,253 | $1,069 |
| Multaq | 53 | $69,573 | $1,313 |
| Xarelto | 24 | $32,490 | $1,354 |
| Dofetilide | 38 | $16,868 | $444 |
| Propafenone Hcl Er | 15 | $5,337 | $356 |
| Propafenone | 55 | $4,430 | $81 |
| Flecainide Acetate | 30 | $2,315 | $77 |
| Amiodarone | 84 | $1,868 | $22 |
| Metoprolol | 62 | $1,801 | $29 |
| Sotalol | 21 | $352 | $17 |
| Oxycodone | 52 | $175 | $3 |
2020: 9 drugs
| Eliquis | 91 | $85,971 | $945 |
| Multaq | 32 | $35,306 | $1,103 |
| Xarelto | 26 | $19,397 | $746 |
| Dofetilide | 11 | $6,645 | $604 |
| Flecainide Acetate | 40 | $3,052 | $76 |
| Propafenone | 32 | $1,968 | $62 |
| Metoprolol | 50 | $1,613 | $32 |
| Amiodarone | 60 | $830 | $14 |
| Oxycodone | 48 | $179 | $4 |
2019: 9 drugs
| Multaq | 53 | $45,873 | $866 |
| Eliquis | 32 | $29,724 | $929 |
| Dofetilide | 42 | $17,427 | $415 |
| Xarelto | 24 | $13,408 | $559 |
| Metoprolol | 20 | $1,177 | $59 |
| Flecainide Acetate | 17 | $1,093 | $64 |
| Propafenone | 12 | $853 | $71 |
| Amiodarone | 42 | $631 | $15 |
| Oxycodone | 56 | $210 | $4 |
2018: 10 drugs
| Multaq | 42 | $48,195 | $1,148 |
| Eliquis | 66 | $44,125 | $669 |
| Xarelto | 39 | $31,274 | $802 |
| Dofetilide | 52 | $23,375 | $450 |
| Metoprolol | 65 | $3,076 | $47 |
| Flecainide Acetate | 36 | $2,391 | $66 |
| Propafenone | 32 | $1,545 | $48 |
| Amiodarone | 55 | $842 | $15 |
| Mupirocin | 35 | $346 | $10 |
| Oxycodone | 50 | $223 | $4 |
2017: 20 drugs
| Eliquis | 87 | $50,022 | $575 |
| Xarelto | 44 | $20,495 | $466 |
| Multaq | 27 | $17,961 | $665 |
| Dofetilide | 31 | $13,864 | $447 |
| Propafenone Hcl Er | 34 | $11,908 | $350 |
| Metoprolol | 112 | $4,649 | $42 |
| Flecainide Acetate | 45 | $2,714 | $60 |
| Amiodarone | 31 | $699 | $23 |
| Propafenone | 16 | $577 | $36 |
| Warfarin | 37 | $504 | $14 |
| Carvedilol | 73 | $408 | $6 |
| Atorvastatin | 17 | $330 | $19 |
| Mupirocin | 21 | $196 | $9 |
| Oxycodone | 48 | $189 | $4 |
| Lisinopril | 16 | $168 | $10 |
| Clopidogrel | 12 | $166 | $14 |
| Amlodipine Besylate | 27 | $163 | $6 |
| Furosemide | 29 | $128 | $4 |
| Metoprolol | 22 | $118 | $5 |
| Losartan | 13 | $108 | $8 |
2016: 25 drugs
| Eliquis | 121 | $46,926 | $388 |
| Multaq | 64 | $37,955 | $593 |
| Xarelto | 76 | $34,503 | $454 |
| Tikosyn | 37 | $21,386 | $578 |
| Propafenone Hcl Er | 39 | $11,083 | $284 |
| Dofetilide | 22 | $9,732 | $442 |
| Metoprolol | 185 | $6,380 | $34 |
| Flecainide Acetate | 108 | $4,934 | $46 |
| Ranexa | 12 | $3,918 | $326 |
| Amiodarone | 62 | $2,040 | $33 |
| Propafenone | 33 | $1,282 | $39 |
| Warfarin | 90 | $1,072 | $12 |
| Diltiazem 24hr Er | 11 | $1,005 | $91 |
| Carvedilol | 75 | $543 | $7 |
| Potassium Chloride | 23 | $366 | $16 |
| Furosemide | 83 | $343 | $4 |
| Metoprolol | 40 | $273 | $7 |
| Lisinopril | 33 | $248 | $8 |
| Clopidogrel | 15 | $223 | $15 |
| Oxycodone | 45 | $207 | $5 |
| Amlodipine Besylate | 33 | $175 | $5 |
| Atorvastatin | 11 | $162 | $15 |
| Losartan | 22 | $124 | $6 |
| Spironolactone | 11 | $50 | $5 |
| Atenolol | 11 | $24 | $2 |
2015: 9 drugs
| Eliquis | 27 | $9,665 | $358 |
| Flecainide Acetate | 19 | $853 | $45 |
| Metoprolol | 12 | $670 | $56 |
| Amiodarone | 24 | $513 | $21 |
| Carvedilol | 17 | $107 | $6 |
| Warfarin | 13 | $100 | $8 |
| Lisinopril | 15 | $65 | $4 |
| Oxycodone | 11 | $59 | $5 |
| Furosemide | 12 | $59 | $5 |
2013: 3 drugs
| Diovan | 12 | $1,915 | $160 |
| Atorvastatin | 19 | $850 | $45 |
| Carvedilol | 24 | $286 | $12 |
Money from drug and device companies
$3,561 in 2025
| 2025 | 6 | 29 | None | $3,561 |
| 2024 | 4 | 23 | None | $3,105 |
| 2023 | 8 | 13 | None | $1,153 |
| 2022 | 2 | 2 | None | $127 |
| 2021 | 2 | 3 | None | $47 |
| 2020 | 3 | 5 | None | $219 |
| 2019 | 3 | 26 | None | $3,947 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Medtronic | Evera Mri Xt Dr Surescan | $2,522 | 15 payments
|
| Abbott Laboratories | Aveir | $904 | 10 payments
|
| Kestra Medical Technology Services | Assure Wcd | $44 | 1 payment
|
| Biosense Webster | Carto 3 | $40 | 1 payment
|
| Getinge USA Sales | Cardiosave Rescue | $36 | 1 payment
|
| CVRx | Barostim Neo System | $15 | 1 payment
|
See all 29 published payments
| Kestra Medical Technology Services | Meals · 2025-12-13 | Assure Wcd | $44 |
| Medtronic | Meals · 2025-10-28 | Aurora Ev-Icd Mri Surescan | $116 |
| Medtronic | Meals · 2025-10-16 | Selectsecure | $167 |
| Biosense Webster | Meals · 2025-09-25 | Carto 3 | $40 |
| Medtronic | Travel · 2025-07-21 | None | $249 |
| Medtronic | Meals · 2025-07-21 | Selectsecure | $19 |
| Medtronic | Meals · 2025-07-20 | Selectsecure | $123 |
| Medtronic | Travel · 2025-07-03 | None | $549 |
| Medtronic | Travel · 2025-03-20 | Evera Mri Xt Dr Surescan | $119 |
| Medtronic | Travel · 2025-03-12 | Evera Mri Xt Dr Surescan | $60 |
| Medtronic | Meals · 2025-03-12 | Evera Mri Xt Dr Surescan | $35 |
| Medtronic | Meals · 2025-03-12 | Evera Mri Xt Dr Surescan | $17 |
| Medtronic | Meals · 2025-03-12 | Evera Mri Xt Dr Surescan | $28 |
| Medtronic | Travel · 2025-03-11 | Evera Mri Xt Dr Surescan | $267 |
| Medtronic | Travel · 2025-03-11 | Evera Mri Xt Dr Surescan | $62 |
| CVRx | Meals · 2025-03-06 | Barostim Neo System | $15 |
| Getinge USA Sales | Meals · 2025-03-01 | Cardiosave Rescue | $36 |
| Medtronic | Travel · 2025-02-25 | Evera Mri Xt Dr Surescan | $175 |
| Medtronic | Travel · 2025-02-25 | Evera Mri Xt Dr Surescan | $536 |
| Abbott Laboratories | Meals · 2025-02-20 | Aveir | $44 |
| Abbott Laboratories | Meals · 2025-02-20 | Aveir | $36 |
| Abbott Laboratories | Meals · 2025-02-20 | Aveir | $63 |
| Abbott Laboratories | Meals · 2025-02-20 | Aveir | $59 |
| Abbott Laboratories | Meals · 2025-02-20 | Aveir | $46 |
| Abbott Laboratories | Travel · 2025-02-20 | Aveir | $187 |
| Abbott Laboratories | Travel · 2025-02-20 | Aveir | $78 |
| Abbott Laboratories | Travel · 2025-02-20 | Aveir | $127 |
| Abbott Laboratories | Travel · 2025-01-20 | Aveir | $254 |
| Abbott Laboratories | Travel · 2025-01-20 | Aveir | $9 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $3,105
| Philips North America | (Bs2) Lm Undivided | $1,477 | 7 payments
|
| Abbott Laboratories | Aveir | $1,360 | 12 payments
|
| Medtronic | Cobalt Dr Mri Surescan | $208 | 2 payments
|
| Biosense Webster | Carto 3 | $59 | 2 payments
|
2023: $1,153
| Medtronic | Micra | $534 | 5 payments
|
| Boston Scientific | None | $150 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $133 | 1 payment
|
| Biosense Webster | Carto 3 | $104 | 2 payments
|
| Philips Electronics North America | (9124) Lm Undivided | $79 | 1 payment
|
| Kestra Medical Technology Services | Assure Wcd | $59 | 1 payment
|
| Abbott Laboratories | Viewmate | $53 | 1 payment
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $42 | 1 payment
|
2022: $127
| Medtronic | Micra | $99 | 1 payment
|
| Abbott Laboratories | Viewmate | $28 | 1 payment
|
2021: $47
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $34 | 2 payments
|
| Medtronic | Carelink | $13 | 1 payment
|
2020: $219
| Boston Scientific | Vigilant | $123 | 2 payments
|
| Medtronic Vascular | Micra | $71 | 1 payment
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $25 | 2 payments
|
2019: $3,947
| Medtronic Vascular | Claria Mri | $2,720 | 14 payments
|
| Boston Scientific | General Therapies | $1,002 | 8 payments
|
| Biosense Webster | Carto 3 System | $225 | 4 payments
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 90.1 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1700051380
- Licence
- WV 27658
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RC0001X (207RC0001X)
- Mailing address
- 3100 Maccorkle Ave Se Ste 900, Charleston, WV, 25304
- NPI first listed
- 2008-04-24
- NPI last updated
- 2019-08-08
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 3100 Maccorkle Ave Se Ste 700, Charleston, WV, 25304 · 3200 Maccorkle Ave Se, Charleston, WV, 25304 · 501 Morris St, Charleston, WV, 25301